Literature DB >> 21335945

Long-term survival in a patient with node-positive adult-onset Xp11.2 translocation renal cell carcinoma.

Toshiki Aoyagi1, Nobuo Shinohara, Kanako Kubota-Chikai, Naoto Kuroda, Katsuya Nonomura.   

Abstract

Adult-onset Xp11.2 translocation renal cell carcinoma is a rare malignancy that has an aggressive clinical course and poor prognosis. The reasons for this include the fact that most patients have an advanced clinical stage at diagnosis and also that there is a lack of effective systemic therapy. We herein present the case of a 32-year-old woman suffering from node-positive Xp11.2 translocation renal cell carcinoma who underwent radical nephrectomy with an extensive retroperitoneal lymph node dissection, followed by two times of surgical resection for recurrent nodal disease. The patient has experienced no recurrent disease 4.5 years after the last operation and remains free of disease. Surgical approach to recurrent disease, if the recurrent site can be judged to be limited, might be one of the feasible treatment options in patients with Xp11.2 translocation renal cell carcinoma.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21335945     DOI: 10.1159/000323866

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  8 in total

1.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

2.  Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

Authors:  Wei Wang; Jianhui Ding; Yuan Li; Chaofu Wang; Liangping Zhou; Hui Zhu; Weijun Peng
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

3.  Mucinous tubular and spindle cell carcinoma with a high nuclear grade and micropapillary pattern: A case report.

Authors:  Toru Sakatani; Yoshinaga Okumura; Naoto Kuroda; Toshihiro Magaribuchi; Yorika Nakano; Toshiaki Shirahase; Jun Watanabe; Yoji Taki; Mitsuhiko Okigaki; Susumu Ikehara; Yasushi Adachi
Journal:  Mol Clin Oncol       Date:  2017-09-29

4.  Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

Authors:  Zhen Wang; Ning Liu; Weidong Gan; Xiaogong Li; Gutian Zhang; Dongmei Li; Hongqian Guo
Journal:  J Int Med Res       Date:  2017-06-06       Impact factor: 1.671

5.  Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers.

Authors:  Jee Soo Park; Myung Eun Lee; Won Sik Jang; Jongchan Kim; Se Mi Park; Won Sik Ham
Journal:  Biomedicines       Date:  2022-01-29

6.  Factors Associated with Survival From Xp11.2 Translocation Renal Cell Carcinoma Diagnosis-A Systematic Review and Pooled Analysis.

Authors:  Yuqing Wu; Saisai Chen; Minhao Zhang; Kuangzheng Liu; Jibo Jing; Kehao Pan; Lihua Zhang; Bin Xu; Xiaoming Lu; Ming Chen
Journal:  Pathol Oncol Res       Date:  2021-03-30       Impact factor: 3.201

7.  Xp11 Translocation Renal Cell Carcinoma: Unusual Variant Masquerading as Upper Tract Urothelial Cell Carcinoma.

Authors:  Arash Akhavein; Julia Han; Christopher Carter; Samer Z Al-Quran; Li-Ming Su
Journal:  Urol Case Rep       Date:  2014-03-31

8.  Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion.

Authors:  Wenwu Ling; Xuelei Ma; Yan Luo; Linyan Chen; Huiyao Wang; Xiaoling Wang; Ni Chen; Hao Zeng; Yongzhong Li; Diming Cai
Journal:  Contrast Media Mol Imaging       Date:  2017-11-23       Impact factor: 3.161

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.